Larvol Delta - Artax-Biopharma-achieves-clinical-validation-of-rstinclass-oral-Nck-modulator-AX158-for-autoimmune-disease-in-phase-2a-study

AX-158 - Artax Biopharma

https://www.prnewswire.com/news-releases/artax-biopharma-achieves-clinical-validation-of-first-in-class-oral-nck-modulator-ax-158-for-autoimmune-disease-in-phase-2a-study-302356945.html

Jan 22, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next